Establishment Labs saw the highest growth of 0.99% in patent filings in April and 4.99% in grants in June in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.99% and no change in grants. GlobalData’s DataBook provides a comprehensive analysis of Establishment Labs’s patent filings and grants. Buy the databook here.
Establishment Labs has been focused on protecting inventions in European Patent Office(EPO) with three publications in Q2 2024
The European Patent Office(EPO) Patent Office dominates the patent grants with nearly 50% of grants. The Israel(IL), United States(US), and European Patent Office(EPO) patent Office are among the top ten patent offices where Establishment Labs is filings its patents. Among the top granted patent authorities, Establishment Labs has 50% of its grants in European Patent Office(EPO), 33% in Israel(IL) and 17% in United States(US).
AbbVie and Becton Dickinson and Co could be the strongest competitors for Establishment Labs
In terms of grant share, Establishment Labs stands in third position among its competitors. AbbVie and Becton Dickinson and Co secured the top positions according to recent patent publication data.
Patents related to 3d printing and cell & gene therapy lead Establishment Labs's portfolio
Establishment Labs has the highest number of patents in 3d printing followed by, cell & gene therapy and healthtech. For 3d printing, nearly 67% of patents were filed and 33% of patents were granted in Q2 2024.
Breast implants related patents lead Establishment Labs portfolio followed by petrochemicals, and general surgery devices
Establishment Labs has highest number of patents in breast implants followed by petrochemicals, general surgery devices, records management. For breast implants, nearly 50% of patents were filed and 33% of patents were granted in Q2 2024.
For comprehensive analysis of Establishment Labs's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.